Solasia Pharma K.K.   Report issue

For profit Phase 2 Phase 3
Founded: Tokyo Japan (2006)
Status: No NME R&D (2006)

Organization Overview

First Clinical Trial
2011
NCT01435863
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Solasia Pharma K.K.